Studies in solid tumors also correlate ABCG2 overexpression with poor prognosis, including supporting evidence in small cell and non‐small cell lung carcinoma, though there is conflicting evidence for breast cancer [66, 67, 68, 69]. Here, ABCG2 is linked to breast carcinoma.